Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
418
NCT02322957
A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2015
Completion: Jul 31, 2015
NCT02412917
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
Phase: Phase 3
Start: Jun 30, 2015
Completion: Nov 30, 2017
NCT02585440
A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects
Start: Apr 30, 2016
Completion: Sep 30, 2016
NCT02710604
Phase 2, Multiple Ascending Dose Proof of Concept Study
Phase: Phase 2
Start: May 31, 2016
Completion: Jul 18, 2017
NCT03279146
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
Start: Sep 6, 2017
Completion: Jun 16, 2018
NCT03284164
Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex
Start: Sep 28, 2017
Completion: Feb 20, 2018